Department of Surgery, UMDNJ-New Jersey Medical School, Newark, New Jersey 07103, USA.
Shock. 2010 Nov;34(5):475-81. doi: 10.1097/SHK.0b013e3181dc3ff5.
There is substantial evidence that gut barrier failure is associated with distant organ injury and systemic inflammation. After major trauma or stress, the factors and mechanisms involved in gut injury are unknown. Our primary hypothesis is that loss of the intestinal mucus layer will result in injury of the normal gut that is exacerbated by the presence of luminal pancreatic proteases. Our secondary hypothesis is that the injury produced in the gut will result in the production of biologically active mesenteric lymph and consequently distant organ (i.e., lung) injury. To test this hypothesis, five groups of rats were studied: 1) uninstrumented naive rats; 2) control rats in which a ligated segment of distal ileum was filled with saline; 3) rats with pancreatic proteases placed in their distal ileal segments; 4) rats with the mucolytic N-acetylcysteine (NAC) placed in their distal ileal segments; and 5) rats exposed to NAC and pancreatic proteases in their ileal segments. The potential systemic consequences of gut injury induced by NAC and proteases were assessed by measuring the biological activity of mesenteric lymph as well as gut-induced lung injury. Exposure of the normal intestine to NAC, but not saline or proteases, led to increased gut permeability, loss of mucus hydrophobicity, a decrease in the mucus layer, as well as morphological evidence of villous injury. Although proteases themselves did not cause gut injury, the combination of pancreatic proteases with NAC caused more severe injury than NAC alone, suggesting that once the mucus barrier is impaired, luminal proteases can injure the now vulnerable gut. Because comparable levels of gut injury caused by systemic insults are associated with gut-induced lung injury, which is mediated by biologically active factors in mesenteric lymph, we next tested whether this local model of gut injury would produce active mesenteric lymph or lead to lung injury. It did not, suggesting that gut injury by itself may not be sufficient to induce distant organ dysfunction. Therefore, loss of the intestinal mucus layer, especially in the presence of intraluminal pancreatic proteases, is sufficient to lead to injury and barrier dysfunction of the otherwise normal intestine but not to produce gut-induced distant organ dysfunction.
有大量证据表明,肠道屏障功能衰竭与远处器官损伤和全身炎症有关。在发生重大创伤或应激后,肠道损伤涉及的因素和机制尚不清楚。我们的主要假设是,肠黏膜层的丧失会导致正常肠道损伤,而肠道内存在的胰蛋白酶则会加重这种损伤。我们的次要假设是,肠道损伤会导致具有生物活性的肠系膜淋巴产生,进而导致远处器官(即肺)损伤。为了验证这一假设,我们研究了五组大鼠:1)未受干预的正常大鼠;2)在结扎的回肠远端填充盐水的对照组大鼠;3)将胰蛋白酶放置在其回肠远端的大鼠;4)将粘蛋白溶解剂 N-乙酰半胱氨酸(NAC)放置在其回肠远端的大鼠;5)将 NAC 和胰蛋白酶暴露在其回肠段的大鼠。通过测量肠系膜淋巴的生物活性以及肠道引起的肺损伤,评估 NAC 和蛋白酶引起的肠道损伤对全身的潜在影响。正常肠暴露于 NAC,但不是盐水或蛋白酶,会导致肠道通透性增加、黏液疏水性丧失、黏液层减少以及绒毛损伤的形态学证据。尽管蛋白酶本身不会引起肠道损伤,但胰蛋白酶与 NAC 联合使用会导致比 NAC 单独使用更严重的损伤,这表明一旦黏液屏障受损,肠道内的蛋白酶就会损伤现在脆弱的肠道。由于全身损伤引起的类似程度的肠道损伤与肠系膜淋巴中的生物活性因子介导的肠道引起的肺损伤相关,因此我们接下来测试了这种局部肠道损伤模型是否会产生有活性的肠系膜淋巴或导致肺损伤。结果并未如此,这表明肠道损伤本身可能不足以引起远处器官功能障碍。因此,肠黏膜层的丧失,尤其是在存在肠道内胰蛋白酶的情况下,足以导致正常肠道的损伤和屏障功能障碍,但不会导致肠道引起的远处器官功能障碍。